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ABSTRACT 
Alzheimer’s Disease (AD) is characterized by episodic memory deficits attributed to 
damage to the hippocampal formation. AD therapies specifically targeting hippocampal 
function may be best evaluated through the use of selective hippocampal tasks. I used a 
nonverbal hippocampal-dependent target-in-scene detection task to determine if task 
performance shows age-related decline and/or AD-related impairments.  Participants 
located objects (‘targets’) that appeared/disappeared in flickering natural scenes, 
yielding faster search times for remembered targets than for forgotten ones. AD patients 
took longer and required more fixations to detect targets, indicating impaired memory.  
Furthermore, the AD and aged populations exhibited slower pupillary responses. As 
part of a clinical trial, I next asked whether deep-brain stimulation of the extended 
hippocampal circuit would modify memory performance in patients with early AD. The 
double-blind treatment trial is still underway, thus treatment efficacy is yet to be 
evaluated, however, trial participants showed a measurable, progressive memory 
impairment in this task. 
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INTRODUCTION 
The hippocampus and memory 
 
Memory is a term used to describe the mechanisms involved in the encoding, 
storage, and retrieval of information over time. Memory is undeniably useful, and we 
rely on it heavily to perform basic daily functions. Memory allows us to recall the 
locations of misplaced items, and helps us navigate the route we use to get from home 
to work; it can also help us respond appropriately to loved ones compared to the way 
we behave around a sworn enemy or a complete stranger. The significance of memory 
in almost every aspect of life has led us to pursue a better understanding of the 
mechanisms responsible for its function and dysfunction. The discovery of amnesia in 
the famous patient H.M. further illuminated the significant role the hippocampus – 
located in the medial temporal lobe - plays in memory (Scoville, & Milner, 1957; 
Brown & Schafer, 1888; Penfield & Boldrey, 1937; Bechterew, 1900). H.M.’s surgery, 
a desperate attempt to remove the brain tissue causing his seizures, included the 
removal of large sections of the medial temporal lobe, which left him unable to 
remember who he had been talking to just 10 minutes prior. His inability to recall 
personal experiences, and events that occurred after the surgery, affected what 
researchers now commonly refer to as episodic memory. This incidental finding would 
be the first to elucidate the possibility of studying memory separate from other 
cognitive abilities, as well as reveal a more detailed depiction of the specific role of the 
hippocampus. A few years later, O’Keefe and Dostrovsky (1971) discovered the 
existence of place cells in the hippocampus, neurons that selectively fired for preferred 
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places in space. O’Keefe and Nadel (1978) postulated that together these place cells 
aided in creating ‘cognitive maps’ of our environments, which we could use for 
navigation. It was later posited that perhaps place cells were not only limited to 
combining information about space and time, but rather may also have the ability to 
create other non-spatial relational links (Konkel & Cohen, 2009; Cohen & Eichenbaum, 
1993). This is the fundamental idea behind relational memory, where the hippocampus 
is thought to create associations among items. 
It is widely accepted that as a person ages, hippocampal synaptic numbers 
decrease and neurons die; this  atrophy has been observed through several different 
imaging techniques (Anderton, 1997; Driscoll et al., 2009; Raz et al., 2004; Raz, 2005). 
Accordingly, older adults begin to exhibit difficulties with hippocampal-dependent 
memory. Although some degree of hippocampal atrophy may be expected, aging is also 
accompanied by increased risk for developing cognitive impairments beyond that 
predicted by age. Many older adults, particularly after the age of 65, are diagnosed with 
having mild cognitive impairment (MCI) (Gauthier et al., 2006). They exhibit 
noticeable cognitive deficits, yet their difficulties are not severe enough to hinder their 
everyday activities, not qualifying as full blown dementia. Although MCI can plateau 
or even reverse, it is far more common for those originally diagnosed with MCI (>80%) 
to experience a conversion into dementia of the Alzheimer’s type (Anderson et al., 
2012). 
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Alzheimer’s Disease 
Alzheimer’s Disease (AD) is a progressive degenerative disease characterized 
by irreversible neuron loss in brain regions that affect cognition. It is the most common 
form of dementia, a set of symptoms often describing memory decline accompanied 
with at least one other cognitive deficit as listed in the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition (DSM-IV), causing an interference with 
day-to-day function (Mckhann et al., 2011). One of the first areas affected in AD is the 
hippocampal formation, including the entorhinal cortex, resulting in memory deficits 
one of the preliminary symptoms (Padurariu et al., 2012). Although the cause of AD 
remains elusive, pathological characteristics of the disease, common in most 
individuals with AD, have been identified. Dr. Alois Alzheimer was the first to 
discover plaques and tangles in the post-mortem brains of demented individuals, 
leading researchers to believe that these plaques and tangles played a crucial role in the 
development of AD pathology (Hippius & Neundörfer, 2003). It is now generally 
accepted that atypical cleavage of a regular transmembrane protein is what leads to the 
smaller, more sticky protein fragments that aggregate into the first of the pathological 
hallmarks of AD, the ‘plaques’ (Minati et al., 2009). The plaques are then thought to 
interfere with neuronal communication, contribute to tangle formation, initiate 
inflammatory responses, and eventually result in cell death (Oddo, 2003; Goedert, & 
Spillantini, 2006; Eikelenboom et al., 1991). The extent to which plaques play a causal 
role in tangle formation is unknown. Debates about which of the two occurs first and 
results in the other, the plaques or the tangles, are ongoing and remain controversial 
(Oddo, 2003; Goedert & Spillantini, 2006; Eikelenboom et al., 1991; Minati et al., 
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2009). Tangles, formed by the hyperphosphorylation of an important cytoskeletal 
protein ‘tau’, have been tightly associated with cognitive status (Ghoshal, 2002; 
Taniguchi et al., 2005). Under normal conditions, the tau protein assists the transport of 
nutrients and waste products from the cell body to the axon terminal. The 
hyperphosphorylation of tau results in it having a disfigured conformation, destroying 
its function in the process (Minati et al., 2009). Contrary to the hypothesis that both of 
these disease hallmarks may play a causal role, emerging evidence reveals that some 
individuals never develop dementia despite large deposits of plaques and tangles (Price 
& Morris, 1999), meanwhile, others that exhibit profound dementia maintain low levels 
of these histopathological markers (Pimplikar et al., 2012). Thus, some researchers now 
suspect that these characteristics may not be causal agents, but merely byproducts of 
the disease (Struble et al., 2010).  
In addition to the amyloid plaques and neurofibrillary tangles, persons with AD 
have lower levels of choline acetyltransferase (ChAT) protein, an enzyme responsible 
for producing the neurotransmitter achetylcholine (Ach), in cholinergic neurons 
(Wilcock et al., 1982). Ach plays a crucial role in learning and memory processes, 
particularly in the hippocampal formation. Interestingly, ChAT levels have been 
associated with the amount of cognitive damage observed in individuals with AD 
(Wilcock et al., 1982). The putative link between cognitive loss and ChAT, however, 
has been disputed with reports of some individuals with AD showing no reductions in 
ChAT (Davis et al., 1999; Palmer et al., 1986). Moreover, other studies have shown 
that persons with different diseases/conditions may exhibit similar degrees of ChAT 
activity, yet experience no cognitive issues (Kish et al., 1989). Taken together, these 
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biochemical foundations thought to be behind the pathogenesis of AD, instead, may be 
factors or by-products from the preceding events that result in the disturbed system.  
Over the last few decades, researchers have found that individuals with AD 
appear to have a higher risk for developing seizures or displaying epileptiform brain 
activity (Amatniek et al., 2006). Epilepsy is a neurological disorder most commonly 
observed as uncharacteristic synchronous brain activity initiated in the medial temporal 
lobe, overlapping the regions primarily affected in AD.  Recent evidence suggests that 
amyloid clusters, which are thought to invade neuronal networks in the hippocampal 
formation in the earliest stages in AD, are what cause the cognitive decline and 
epileptiform brain activity observed (Yan et al., 2012; Palop & Mucke, 2011; Palop & 
Mucke, 2009; Palop et al., 2007; Palop et al., 2006). Other studies argue that the brain 
activity typical of epilepsy may be what underpins the cognitive problems experienced 
(Uhlhaas, & Singer, 2006; Griffith et al., 2006). In addition, one study found that under 
normal conditions mice that had theta (3-8 Hz) and gamma (30-90 Hz) frequency 
coupling - important for normal cognitive function – began to show alterations in 
oscillatory coupling. These frequency coupling changes observed led to impairments on 
spatial memory tasks, even before any amyloid or plaques were formed (Goutagny et 
al., 2013). Furthermore, cognitively impaired rodents with hippocampal hyperactivity, 
thought to result from amyloid clusters, were treated with commonly used antiepileptic 
drugs and experienced improvements in spatial memory tasks (Koh et al., 2010). 
Despite all the research that has been done in attempts to uncover the etiological root of 
the disease, many questions regarding the pathogenesis of AD remain unanswered. 
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While a cure for AD remains elusive, and as the prevalence of the disease is on the rise, 
effective treatment strategies are of increasing importance. 
Current treatments for AD mainly consist of pharmacological agents.  In the 
early to intermediate stages of AD, physicians often prescribe cholinesterase inhibitors 
as treatment (Winblad & Jelic, 2004). As the name suggests, these drugs inhibit the 
enzymatic activity of the protein that breaks down acetylcholine, leading to increased 
levels of the neurotransmitter at the synapses where learning and memory processes 
occur. Although it has been documented on several accounts that cholinesterase 
inhibitors are able to delay disease-related symptoms, the drug’s effects appear to be 
temporary, usually lasting up to one year from initial use. In the intermediate to severe 
stages, doctors will often refer patients to ‘memantine’, an NMDA antagonist. In 
healthy individuals, the mechanisms underlying learning and memory depend on the 
binding of the neurotransmitter glutamate to its receptor NMDA. However, individuals 
with AD have elevated levels of glutamate, which can lead to the over-excitation of 
neurons, resulting in their death (Francis, 2003). Memantine works by blocking NMDA 
receptors from glutamate, regulating its activity. The effects of this drug are 
controversial: some studies show benefits in the earlier stages of AD (Bakchine & Loft, 
2008); others claim is do not (Dysken et al., 2014). Even in the later stages, however, it 
is often recommended to be used alongside cholinesterase inhibitors for increased 
efficiency (Tariot et al., 2004).  Vitamin E, a powerful antioxidant, has also been used 
in high doses as a potential treatment. However, the effects of one study that showed its 
possible benefit in AD have yet to be replicated (Dysken et al., 2014). The effects of the 
aforementioned drugs are not only limited, but their benefits appear to be lost with 
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time. Considering the limited efficacy of current pharmacological treatments, and the 
recent discovery of physiological/circuit dysfunction at early stages of the disease, 
treatments that target the excitability of cell populations may be useful options. 
Additionally, researchers are also stressing the importance of earlier diagnosis for 
optimal treatment results, and this may depend on selective tests that are able to detect 
changes in brain areas that are primary targets of the disease.  
In my Master’s work, I set out to investigate the following hypotheses: 
1. Memory diminishes as a function of age and AD, as measured by longer 
repeated trial search times  
 
2. The Autonomic Nervous System (ANS), which controls the change in pupil 
size, experiences dysfunction in Alzheimer’s Disease; thus, diminished 
autonomic responses in AD we would be able to measure via pupillary 
responses 
 
3. The AD patients receiving the DBS-f treatment would experience a 
reduction in memory decline 
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Chapter 2: 
 
Pupillary response and visual search performance identify and separate age-
related from Alzheimer’s-related memory decline 
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I N T R O D U C T I O N  
Episodic memory is known to decline with aging, but even more so in progressive 
dementias such as Alzheimer’s Disease (AD), where it constitutes one principal 
criterion for diagnosis. These memory deficits generally follow the course of damage to 
the hippocampus and interconnected medial-temporal lobe (MTL) structures in AD 
(Braak and Braak, 1991; van Hoesen et al., 1991), consistent with the suggested role of 
the MTL in forming spatiotemporal associations that support episodic memory 
(Burgess et al., 2002, Cohen and Eichenbaum, 1993). Some of the most commonly 
used clinical measures of cognitive decline in AD, such as the Alzheimer’s Disease 
Assessment Scale – Cognitive test (ADAS-cog) and the Mini Mental State Examination 
(MMSE), emphasize an array of cognitive functions and use verbal report, constraining 
their specificity to memory for spatiotemporal associations that may index MTL 
degeneration with AD. In addition, the sensitivity and specificity of these tests have 
been questioned due to practice effects and variation in experimenter scoring (Galasko 
et al., 1993; De Jager et al, 2003). (Elfgrenetal.,1994; Chenetal., 2000; Simons et al., 
2002; Thompson et al., 2005; Tierney et al., 2005). 
In response to this, several memory tests have been conducted in AD patients that 
require or correlate with some type of hippocampal or MTL activity, including 
sequential spatial route-taking from virtual navigation (Belassen et al., 2012), and 
recognition memory that requires pattern separation among similar objects (Stark et al., 
2013). Whereas these tasks include spatial memory and pattern separation/recollection 
memory requirements, respectively, both thought to depend on hippocampal function, a 
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distinction has been made between these abilities and those necessary for episodic 
memory (Aggleton et al., 1999; Burgess et al., 2002; Moscovitch et al., 2005), thus 
there may be grounds for tests of complementary, episodic-like, MTL-dependent 
processes. In addition, measures that are diagnostic at one stage of disease progression 
may not be optimal at other stages, necessitating different tasks or different task 
versions. Finally, for treatments that target specific neural structures, the tasks best-
suited to determine their efficacy are presumably those most sensitive and specific to 
the function of those structures. 
Here, we present a scene search task that measures hippocampal-dependent single-trial 
memory for objects-in-context, while avoiding confounds with language or visuomotor 
skills which have been shown to be impaired in the AD population (Tippett & Sergio, 
2006; Tippett et al., 2007). In this task, rapid detection of the embedded object on 
repeated trials indicates explicit memory for the object in that scene (Chau et al., 2013). 
We hypothesized that memory would decline with age and additionally with AD status, 
measured as an increase in repeated-trial search times. Furthermore, memory for scenes 
alters the pupillary response (Naber et al., 2013), which is regulated by the autonomic 
system (Bitsios et al., 1998; Samuels & Szabadi, 2008; Gilzenrat et al., 2010). Because 
the autonomic system is known to be dysregulated in MCI and early AD (Collins et al., 
2012; Femminella et al., 2014), we also measured pupillary responses to these scenes to 
determine if memory-related autonomic responses are diminished in the AD population. 
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M A T E R I A L S  A N D  M E T H O D S  
 
Participants. Seventeen university students (5 males, ages 19 – 32 years, mean(SD) age 
22.8(3.1) years), 21 older adults (5 males, mean(SD) age 67.3(8.5) years) and 9 older 
adults  diagnosed with probable early AD (5 males, mean(SD) age 69.1(7.8) years), 
participated in the study. Older adults completed the Montreal Cognitive Assessment 
(MoCA) a brief neuropsychological test shown to be sensitive to mild cognitive 
impairment (MCI; Nasreddine et al, 2005; Damian et al., 2011; Marwick et al., 2012) to 
conversion from MCI to AD (Julayanont et al., 2014) and to individuals at risk for 
developing MCI (Newsome et al., 2013; Nasreddine et al., 2005). Ten older adults 
scored a 26 or higher (range: 26 – 31) on the MoCA and therefore were categorized as 
healthy older adults; seven scored 24 or lower (range: 21-24) and were categorized as 
at-risk for developing MCI (Damian et al., 2011). Three individuals scored a 25 and 
could not be placed in either category, thus they were excluded from further analysis. 
One older adult participant was excluded due to difficulty obtaining consistent eye 
tracker signal.  The probable early AD designation was given according to the National 
Institute of Aging Alzheimer’s Association criteria (Jack Jr. et al., 2011). These 
participants were recruited as part of a clinical trial involving deep brain stimulation 
(DBS) at Toronto Western Hospital. To enroll in the clinical trial, patients must have 
scored between 12-24 on the Alzheimer’s Disease Assessment Scale –cognitive test 11 
(ADAS-cog11; Cano et al. 2010), and either 0.5 or 1 on the Clinical Dementia Rating 
(Morris, 1997). The main experiment described here took place after device 
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implantation but before initiation of DBS treatment (or placebo); pre-operative results 
from a subset of participants are included, for comparison.  
 
All participants had normal or corrected- to-normal vision. Participants were informed 
about the purpose of the experiment and its risks, and written informed consent was 
obtained. Younger adult and older AD participants volunteered without monetary 
compensation; older adults received $10/hr in accordance with our ethical guidelines. 
Experimental procedures for all participants were approved by the York Human 
Participants Review Subcommittee; older adults recruited from Rotman Research 
Institute database (N=7) additionally followed the guidelines approved at the Rotman 
Research Institute; early AD participants were selected for and participated in the 
clinical trial in accordance with the ethical guidelines set by the research ethics board 
(REB) of the University Health Network and the Center for Addiction and Mental 
Health. 
  
Stimuli. We selected  a range of natural scenes, including wildlife, city, rural, and 
indoor scenes, that could be displayed at 1280 x 1024 pixel resolution (full screen), as 
described previously (Chau et al., 2011; Hoffman et al., 2013). One object per scene 
was modified (color change or disappearance, Figure 1A) using Adobe Photoshop (San 
Jose, CA). To discourage bias in search strategies, sets of images were balanced for 
target location (quadrant on screen) and category (animate/inanimate). 
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Experimental apparatus and session design. Participants used a chin rest to minimize 
head movements throughout the study. A 38.0 x 30.5cm monitor displaying the task 
stimuli was placed 51cm away from young participants, and 61-63cm away from all 
other participants. Eye gaze and pupil diameter were tracked using the iView X infrared 
eye tracking system at 60 Hz sampling rate (SensoMotoric Instruments, SMI, Berlin, 
Germany), following 13-point calibration and validation. Stimulus presentation 
software (Presentation, Neurobehavioral Systems, CA, USA), received online gaze 
position information from iView enabling gaze-contingent experimental control and 
sent event codes to the iView data acquisition stream for alignment of eye position data 
to trial events. Image selection, presentation timing, and response buttons were also 
controlled in Presentation. After calibration, three example trials were given to ensure 
that participants understood the task. Participants then began with Experiment 1: flicker 
change detection followed by Experiment 2: target detection. 
 
Experiment 1: Flicker change detection memory task (Figure 1B). Each trial consisted 
of the 500ms presentation of an original image (Image A) which alternated with the 
500ms presentation of a modified version of that same image lacking the target object 
(Image A’). Critical to the appearance of a ‘flicker’, a gray screen lasting 50ms was 
inserted between each image alternation (as shown in Figure 1B). This visual 
interruption makes the changed object difficult to detect; however, once detected, the 
change is difficult to ignore (Rensink et al., 1997; Simons & Levin, 1997). Trials ended 
when the target object was detected, i.e. fixated for 1 second, or after 45 seconds of 
cumulative on-screen viewing time, whichever came first. At the end of each trial, 
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whether the target object was detected or not, the gray screen between scenes was 
removed, revealing the target object to the participant as a single blinking object on an 
apparently static background. Immediately following the reveal of each trial, a verbal 
report screen would appear asking the participant, “Was this the first time you saw this 
picture?” Participants gave yes/no answers that were logged by button press for later 
analysis of scene familiarity. The flicker task consisted of 2 sets of 20 trials. Each set 
contained 10 novel images, and those same 10 images repeated after 2-4 intervening 
trials, therefore each participant could have remembered a maximum of 20 targets in 
the flicker task.  
 
Experiment 2: Uncued target detection memory task (Figure 1c). This task is described 
in Hoffman et al., (2013). Briefly, in each target detection trial the original image 
(including the target object) was presented for five seconds, or until the participant 
fixated on the target object for one second, whichever came first. A reveal followed 
each trial end, whereby the target object appeared to blink, exactly like the reveal in the 
flicker task. Because the target object was uncued during the trial, participants would 
simply scan novel images for the maximum trial length until the reveal instructed them 
on which object was that scene’s ‘target’, which participants were asked to remember. 
Each participant saw a series of 10 images, and this series was repeated 4 times, 
allowing 3 chances to demonstrate memory for a given image. Only a subset of the AD 
group (N=3) participated in Experiment 2, and some of these participants had been 
exposed to the images approximately two weeks prior to the testing date of this study; 
however, their search times on the first image presentations in this session were 
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comparable to the search time performances of individuals who were never before 
exposed to the images.  
 
 
 
Figure 1. Experimental design. A) Example stimulus. Image A is the original image 
containing the target object outlined in yellow, where Image A’ is a modified version of 
Image A with the target object absent. The yellow outline is for illustrative purposes 
only and was absent during the task. B) Flicker change detection trial sequence on 
testing sessions. At the end of each trial, a verbal report screen was shown prompting 
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the participant for their recognition of the scene. C) Target detection trial sequence on 
testing sessions. 
 
 
Data analysis.  
Fixation times and locations were calculated with iView X iTools IDF Event Detector, 
using a dispersion based algorithm with a minimum fixation duration of 80ms and 
maximum dispersion of 100 pixels (Salvucci & Goldberg, 2000). Fixation times and 
locations, and pupil diameter was then analyzed using MATLAB (Natick, MA). Search 
measures were calculated from trial onset to the time of target detection. The algorithm 
for detection selected the first fixation in a given trial’s ‘target’ area of interest (AOI) 
that led to one second of fixating in the AOI with no more than one fixation outside of 
the AOI. Drift correction was applied between trials, to ensure accuracy of the AOI. 
Search times for each trial excluded the times that participants spent looking outside of 
the screen dimensions.  
 
To quantify the spatial dispersion of fixations, we calculated entropy from the center of 
the scan path: H=ln(σ1 σ2), where σ1 and σ2 represent orthogonal directions of maximal 
search variance  around the search centroid (‘Hpath’ in Maei et al., 2009). This measure 
was shown to be a sensitive measure of memory-guided “search”, expressed as changes 
in the swim path of mice with hippocampal damage and APP-mutant mice modeling 
Alzheimer’s pathology. For each participant we calculated the average repeated-trial 
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entropy, search time (time from onset to detection) number of fixations per trial, and 
scene familiarity (correctly remembered rate – falsely remembered rate) then group 
differences were statistically evaluated. We compared group responses with the 
Kruskal-Wallis test (non-parametric ANOVA) and, if significant at a two-tailed alpha 
level of 0.01, pairwise post-hoc tests (Wilcoxan rank sum) were run to test for 1) 
Alzheimer’s-related performance differences, (comparing AD patients to healthy and 
at-risk age-matched older adults) and 2) aging effects (comparing young adults to 
healthy and at-risk older adults). 
 
Horizontal pupil diameter was sampled from each trial at 60 Hz. For each trial, values 
were mean-subtracted from the baseline levels taken from a 500ms window leading up 
to trial onset. Pupil response velocity (first derivative of diameter samples) was 
calculated around the time of trial onset and averaged for a given trial type 
(novel/repeated) for each participant. The time of maximal velocity of repeated trials 
across all participants was used as the reference time point to compare peak velocities 
across groups using an ANOVA, followed by post-hoc paired tests to determine 
differences between groups. The repeated-trial effect was measured as the difference in 
velocity (repeated – novel trials) for each participant as a function of time from trial 
onset. Group averages were calculated and for each group, differences from the null 
hypothesis (no difference between novel and repeat velocities) was tested and 
Benjamini-Hochberg FDR corrected to account for multiple comparisons (Benjamini & 
Hochberg, 1995).    
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R E S U L T S  
 
Experiment 1: Flicker Change Detection Memory Task 
Visual scan paths. 
 
The dispersion of repeated-trial scan paths (Figure 2A, light blue lines) differed across 
groups (H(3, 44)=29.25, p=1.9 x 10
-6
). They were more focused (e.g. less diffuse) in 
healthy younger adults than in healthy or at-risk older adults (younger – healthy older: 
W(n1=17,n2=10)=190,  p=0.013;  younger – at-risk: W(n1=17, n2=8)=163, p=6.5 x 10
-4
). Within 
the aging populations, AD patients displayed the most diffuse repeated-trial search, 
compared to healthy (W(n1=9, n2=10)=133, p=8.7 x 10
-5
) and at-risk (W(n1=9, n2=8)=40, 
p=9.8 x 10
-4
) older adults, and there was a trend for at-risk adults to also show more 
diffuse search compared to healthy older adults (W(n1=10, n2=8)=96, p=0.068). The degree 
of dispersion can be influenced by the duration of scan paths, e.g. when objects are 
remembered and therefore located quickly. To address this, we evaluated the number of 
fixations and the search times on repeated trials. 
 
The average number of fixations on repeated trials showed group effects similar to 
those seen with the entropy measure (H(3, 44)=36.27, p= 6.5 x 10
-8
), including an age-
related increase in average number of fixations before target detection (younger adults 
v. healthy older adults: W(n1=17, n2=10)=222, p= 4.2 x 10
-5
; younger adults v. at-risk older 
adults: W(n1=17, n2=8)=169, p=1.7 x 10
-4
). AD patients showed a clear impairment, with 
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more fixations than healthy adults (W(n1=9, n2=10)=135, p=2.1 x 10
-5
) and at-risk older 
adults (W(n1=9, n2=8)=36, p=8.2 x 10
-5
).  
 
 
Figure 2. Memory-guided visual search during flicker change detection. A) 
Superimposed scan paths during novel and repeated flicker trials. Scan paths for an 
example scene were taken from a single participant from each group. Scan paths for 
novel trials are shown in purple, while scan paths for repeated trials are shown in light 
blue. B) Entropy from center of movement in repeated trials across populations. (YA = 
Young Adults (N=17), HOA = Healthy Older Adults (N=10), ROA = at-Risk Older 
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Adults (N=8), AD = Alzheimer’s Disease patients (N=9)). The mean entropy calculated 
relative to the center of the eye scan path measured for each group, where higher values 
indicate greater movement disarray. Error bars represent the standard error of the mean. 
C) Number of fixations in repeated trials across populations. The mean number of 
fixations displayed as bars for repeated trials for each group. D) Median search time for 
target detection in repeated trials across populations. The averaged median search time 
in seconds for detecting target objects in repeated trials for each group. Error bars 
represent the standard error of the mean.  
 
As expected, more fixations in aged and particularly AD- groups corresponded to 
longer search times for target detection in repeated trials (H(3, 44)=34.72, p= 1.4 x 10
-7
). 
Younger adults found the repeated target faster than healthy (W(n1=17, n2=10)=219, p=7.9 
x 10
-5
) and at-risk (W(n1=17, n2=8)=165.5, p=7.3 x 10
-4
) older adults, and AD patients took 
significantly longer to find repeated target objects than their healthy (W(n1=9, n2=10)=135, 
p=2.2 x 10
-5
) and at-risk (W(n1=9, n2=8)=36, p=8.2 x 10
-5
) age-matched counterparts, 
demonstrating both age and AD-related memory impairments for the objects in the 
scenes.  
 
Familiarity (old/new) judgments for the scenes were worse for AD patients than all 
other groups (younger adults: W(n1=9, n2=17)=60.5, p=4.8 x 10
-4
, healthy older adults: 
W(n1=9, n2=10)=50, p=2.4 x 10
-4
, at-risk older adults: W(n1=9, n2=8), p=7.4 x 10
-4
) indicating 
that the AD patients were impaired on this measure; however, no differences in scene 
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familiarity among the young adults and other older adults were detected, and two of the 
AD patients were at ceiling .  
 
AD group controls. 
The memory performance of the AD patients was measured before any clinical 
treatment was applied, but after a surgical procedure that took place approximately two 
weeks prior to their participation in this study. To rule out the impact of the procedure 
on their performance, we analyzed the performance of eight of the AD patients on the 
same experimental design but with a unique set of scenes, prior to any surgical 
procedure. Their performance, before and after surgery, did not differ for any of the 
measures (entropy from center of movement, the number of fixations in repeated trials, 
and median search time for repeated targets).  
 
Pupillary responses. 
 
Based on previous literature showing memory-based changes in pupillary responses in 
young adults, we analyzed pupillary responses to novel and repeated images for all 
groups. Both novel and repeated images elicited rapid constriction of the pupil, though 
the response velocity differed across groups. Younger adults had higher peak velocity 
than any older group (v. HOA t(25) = 3.69, p = 0.001; v. ROA t(22) = 3.76, p = 0.011; 
v. AD t(24) = 7.07, p = 2.61 x 10^-7), and healthy older adults had higher peak velocity 
than did the AD group (t(15) = 3.03, p = 0.008). Furthermore, repeated trials evoked 
faster velocities than novel trials, but only in healthy populations, i.e. in younger (t(16) = 
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4.71, p = 2.4 x 10^-4) and older adults (t(9) = -3.26, p = 0.01), but not in the at-risk or 
AD groups (Figure 3b). Our results indicate that image onset evokes a general pupillary 
response that weakens with age and dementia, and that memory-dependent differences 
in pupillary responses could segregate healthy from at-risk and already-impacted 
populations. 
 
 
 
 
Figure 3. Pupillary responses following image onset. A) Average pupil velocity 
following image onset in novel and repeated trials across groups. Novel-trial velocity 
indicated with dotted lines; repeated-trial velocity with solid lines. Color conventions 
describe in inset. Inset. Average repeated-trial peak velocity for each group. Error bars 
= SEM. YA = Younger Adults (N=17), HOA = Healthy Older Adults (N=10), ROA = 
at-Risk Older Adults (N=8), AD = Alzheimer’s Disease patients (N=9). B) Memory-
related pupillary response following image onset. Shown are the average within-subject 
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differences between novel- and repeated-trial pupil velocity, for each group. Color 
conventions are the same groups as in Figure 3A.  The times of significant differences 
between novel and repeated velocities are plotted at the top of the plot, in colors 
corresponding to the groups: younger adults in blue (p<0.001) and healthy older adults 
in green (p<0.01), both FDR corrected for multiple comparisons.   
 
 
Experiment 2: Target Detection Task  
Target detection search times.  
 
In the target detection task, the image remains on and only after 5 seconds is the target 
object ‘revealed’. Whereas all groups detected the targets after several repetitions, there 
were group differences in the rate of learning, as measured by the search times on the 
first repetition of each image (H=22.68 (2, N=38), p= 4.7 x 10^-5). AD patients were 
impaired in their detection of target objects compared to their healthy (W(n1=4, 
n2=10)=46, p= 0.0028) and at-risk (W(n1=4, n2=8)=42, p= 0.004) age-matched 
counterparts. We also found age-related differences between younger adults and 
healthy older adults (W(n1=17, n2=10)=183, p=0.001) and with those in the at-risk 
group (W(n1=17, n2=8)=155.5, p=0.003).  
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Figure 4. Search times to detect target on the first repetition. The average median 
search times for detecting target objects per group (YA = Young Adults (N=17), HOA 
= Healthy Older Adults (N=10), ROA = at-Risk Older Adults (N=8), AD = 
Alzheimer’s Disease patients (N=4)) on the first repetition of the non-cued images. 
Errors bars represent the standard error of the mean. ** = p<0.005. 
 
 
D I S C U S S I O N  
 
Changed objects in natural scenes are detected using contextual cues (Brockmole et al., 
2006; Hollingworth, 2006; Torralba et al., 2006; Becker and Rasmussen, 2008) and this 
process is thought to require MTL function (Chau et al., 2013; Smith and Squire 2008; 
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Ryan and Cohen, 2004). Here, we use two variations of search-related target detection 
to reveal performance differences in  
 
It has been widely documented that in the earliest stages of Alzheimer’s disease, the 
hippocampus is one of the primary areas affected resulting in memory deficits. Earlier 
treatment administration has been shown to produce better treatment outcomes, 
emphasizing the importance of early diagnosis. In line with this view, it is crucial to 
have the most sensitive instruments for detecting performance changes resulting from 
damage to those primarily affected brain regions. Traditional cognitive batteries used 
with the Alzheimer’s population include the ADAS-cog and the MMSE. These tests are 
comprised of multiple subcomponents that test several cognitive domains including 
memory, as measured by word recall. Performance on these tests may be confounded 
by language ability, rendering an individual with intact memory, but impaired language 
skills, to be incorrectly labelled as memory impaired. These possible confounds in 
language ability have made non-verbal measures of memory increasingly appealing.  
 
Few studies have implemented the use of non-verbal virtual environments in detecting 
dementia, however, many of the actual memory test measures used in these studies 
require verbal responses (deIpolyi et al., 2007; Cushman et al.,2008; Zakzanis et al., 
2009). Other studies that manage to employ non-verbal virtual environments for 
detecting dementia, require the use of joysticks or mice for navigation (Bellassen et al., 
2012). Yet, the implementation of joystick usage to navigate about the environment 
may pose a problem with various cognitively impaired populations. The ability to 
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integrate visual and motor information appears to be compromised in individuals with 
MCI and AD (Tippett & Sergio, Tippett et al., 2007; 2006; Salek et al., 2011). Thus, 
tests involving the use of joysticks or mice that aim to measure cognition may be 
confounded by deficits in visual-motor integration.  
 
A human analogue of the spatial-temporal Morris Water Maze test is an example of 
another nonverbal memory test that has been used with AD patients (Laczo et al., 
2010). However, older individuals may find this test to be lengthy and tiresome. As 
well, safety of such a test may be put to question as issues regarding motor abilities and 
balance increase with aging populations.   
 
The use of computerized cognitive batteries, such as the CANTAB, is becoming a 
preferred method of cognitive testing with researchers and clinicians. Computerized 
versions of cognitive tests minimize scoring errors, variations in administration, and 
can reduce practice effects observed with the pencil and paper versions of these tests 
(Zygouris & Tsolaki, 2014). In particular, paired associates learning (PAL) – a test that 
measures the ability to remember associations among elements of an experience – has 
been argued to be an ideal paradigm for detecting AD impairments (Lowndes & 
Savage, 2007). The PAL of the CANTAB requires individuals to form object-location 
associations with different patterns inside boxes appearing in different locations on the 
screen. Although this version of PAL has been shown to distinguish between groups of 
older adults from those with MCI and AD (Lee et al., 2003; Swainson et al., 2001; 
Fowler et al., 2007), it does not deliver a naturalistic experience of everyday life.  
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Scenes from our day-to-day life exhibit ‘crowding’, that is, the many complex features 
from various objects are combined to create our perception of the multifaceted 
environment we perceive as a whole. However, the unique characteristics of objects 
that help us to identify them seem to be lost with the characteristics of other objects 
immediately surrounding them, making object recognition in this ‘crowded’ view more 
effortful (Pelli & Tillman, 2008). Unlike the PAL of the CANTAB, where crowding is 
virtually diminished, the natural scenes in the change detection task provide a similar 
intensity of ‘crowding’ as expected in real-life environments. Similarly, an additional 
benefit of the change detection task is that it provides for a more realistic simulation of 
daily life events in which we depend on our memory, such as having to remember 
where in the house we last had our keys. Our task also provides a natural method of eye 
tracking, an activity we continuously take part in, as compared to having to tap parts of 
a screen.  
 
Eye tracking provides a wealth of information about several different eye measures, 
reflecting even our subconscious efforts in cognitive tasks. Our paradigm revealed that 
AD patients fixate much more in repeated trials than their age-matched counterparts, 
lending support to previously reported data in line with these results. Similarly, 
researchers have postulated that pupillary responses may be a window into the 
neurophysiological processes that underlie cognitive functions (Laeung et al. 2012). It 
is well known that pupil dilation directly reflects norepinephrine (NE) release from the 
locus coeruleus (LC), a brain structure that has also been implicated in memory 
consolidation and other cognitive processes (Beatty & Kahneman, 1966; Laeng et al. 
29 
 
2012; Verney et al., 2004; Privitera et al., 2010). The simultaneous activation of the 
LC-NE system and the presence of the pupillary response led to the belief that pupillary 
dilations may be a reflection of LC-NE engagemement (Koss, 1986). Thus, researchers 
had discovered a potential noninvasive, continuous physiological measure of LC 
activity. In fact, pupillary dilations have been observed in novelty-recognition tasks, as 
well as tasks measuring memory load with varying lengths of numbers (Verney et al. 
2004; Beatty & Kahneman, 1966). Moreover, pupillary dilations have been positively 
correlated with target detection in complex natural scenes, even when participants did 
not report awareness of the target presence (Privitera et al. 2010). Our results showed 
that AD patients exhibited a decreased pupillary response to target detection in repeated 
trials compared to all other groups. Strikingly, this measure showed significant 
differences in pupillary response between healthy older adults and those in the at-risk 
group prior to target detection, with the at-risk group responding similarly as the AD 
patients.  
 
In our second experiment, we tested the use of a non-flicker version of the task with the 
added benefit of rapid employment to assess its sensitivity in detecting mild AD. A 
substantial burden of cognitive testing for clinicians and researchers comes from the 
time needed to administer such tests. Many of the cognitive instruments that rely on 
nonverbal measures of memory are time consuming, increasing the likelihood that 
participants will quit or become fatigued, rendering results questionable in terms of 
accuracy. The AD population continued to exhibit impairments on the shorter memory 
assay, which also lacked the flicker as a potential perceptive compound. Importantly, 
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this version of the task may be rapidly administered with a maximum six minute time 
period, and continues to be sensitive in detecting impairments from mild AD. 
 
One future direction to supplement the findings of this paper could include testing 
individuals with MCI. This unique non-verbal hippocampal-dependent naturalistic 
memory test is capable of detecting memory impairments in those at-risk for MCI and 
individuals with mild AD. Thus, this test can be expected to be able to detect 
intermediate level memory impairments of those with diagnosable MCI. In addition, 
comparing measures of this test to hippocampal volumetrics would lend support to the 
task’s ability of detecting behavioral changes as a consequence of altered hippocampal 
volume.  
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Chapter 3: 
Assessing the effects of Deep Brain Stimulation to the fornix (DBS-f) in mild AD 
using the change detection task 
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I N T R O D U C T I O N  
The brain is unquestionably the most complex organ in the human body. For 
years researchers have dedicated themselves to try to understand the ways in which its 
structure and function collectively go on to produce our experience of reality. In the 
early 1900’s, Dr. Wilder Penfield probed parts of the cerebral cortex in an attempt to 
find the seizure-causing brain tissue in a patient with untreatable epilepsy. This 
experimental stimulation of the cortex led to the first understanding of cortical function 
in motor and sensory processes, and granted stimulation value in studying the brain 
function (Penfield & Boldrey, 1937). It was not until the introduction of stereotactic 
surgeries, which introduced an effective head restraining method allowing controlled 
and accurate electrode placement, that researchers could begin to elucidate the 
functional role of deeper brain structures, such as the hippocampal formation (Elias, & 
Lozano, 2010). The hippocampal formation is essential for memory, including input 
from the entorhinal cortex (EC), and outputting information through the subiculum 
(Amaral & Witter, 1989).  This stimulation procedure, referred to as Deep Brain 
Stimulation (DBS), acts like a ‘pacemaker’ for the brain. Through the production of 
electrical pulses that target specific brain areas, DBS ultimately aids in altering 
irregular brain activity (Elias, & Lozano, 2010).    
Over the last few decades, DBS has grown in popularity as a surgical treatment 
for several neurological conditions.  In addition to its ability to manage the symptoms 
for a variety of movement disorders, such as Parkinson’s disease and dystonia, DBS has 
been shown to have surprisingly therapeutic benefits for various mood disorders 
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including treatment-resistant depression (Elias, & Lozano, 2010). It became clear to 
researchers that by altering the structures and circuits targeted, DBS demonstrated the 
potential to aid in the management of a number of neurologically-derived conditions 
that had previously proven difficult to treat using existing interventions. An important 
association would be uncovered linking the potential benefits of DBS to Alzheimer’s 
Disease (AD) when one such study was conducted by Lozano and colleagues (Hamani 
et al., 2008). In their initial experiment, they hypothesized that DBS may help manage 
obesity via stimulation of specific hypothalamic sub-regions known to be core 
structures responsible for appetite and satiety. However, when they performed electrode 
stimulation on a morbidly obese patient, they unexpectedly observed that the patient 
was suddenly able to recall very vividly an event that occurred several decades prior. 
Lozano and colleagues proceeded to test the patient on numerous recall and recognition 
tasks while alternating the stimulation from on to off without the patient’s awareness. 
They observed that the patient had memory enhancements that accompanied the 
stimulation, leading Lozano and colleagues to speculate that these changes may have 
resulted from accidental excitation of the fornix, a structure located slightly anterior to 
the hypothalamus. Furthermore, studies have shown that lesioning the fornix, which 
acts as one of the main input/output structures of the hippocampus, creates similar 
impairments as those attributed to hippocampal damage (Cassel et al., 1998; Fletcher et 
al., 2006).  
There have been a few studies that have reported memory enhancements from 
stimulating hippocampal inputs in both animals and humans. Previous literature has 
shown that DBS to the Entorhinal Cortex (EC) - another input structure to the 
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hippocampus - in mice, leads to increased neurogenesis in the hippocampus (Stone et 
al., 2011). Consequently, those newly created neurons grow and take on a similar 
morphology as mature neurons in the hippocampal network, later interconnecting with 
the surrounding circuitry. The addition of these neurons to the memory circuitry is 
thought to underlie the resulting improvements observed in the Morris water maze 
spatial memory task. Moreover, stimulating the EC in epilepsy patients leads to 
improved memory for navigating in a virtual environment (Suthana et al., 2012). Both 
of these studies suggest that DBS targeting hippocampal function may benefit memory, 
which may prove to be especially useful for individuals with impaired memory 
(Hamani et al, 2008). In fact, rodent studies have shown that fornix stimulation 
increases co-modulatory activity in the hippocampus that predicts successful memory 
retrieval, and in this way can help to improve spatial memory performance in otherwise 
amnestic animals (Shirivalkar et al., 2010).  
Persons with AD, who experience difficulties with memory as a result of 
damage to the hippocampal formation, are an example of one such group that may 
benefit from this type of treatment. After the previous experiment revealed the potential 
benefit of DBS on memory, Lozano and colleagues investigated the effects of DBS on 
AD. They hypothesized DBS may lessen or even possibly reverse the memory decline 
presented in AD. They ran a Phase I safety clinical trial delivering stimulation to the 
fornix in 6 mild AD patients and assessed memory performance using the mini mental 
state examination (MMSE) (Laxton et al., 2010). The MMSE is a brief screening 
questionnaire that measures cognitive impairment (Tombaugh & McIntyre, 1992). They 
compared the rate of change in performance in an 11 month period before having 
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surgery, to the rate of change in performance in the 11 month period after having 
surgery, while receiving stimulation. Stimulation was able to lessen the decline in 
performance in majority of the patients, and even reversed performance impairments in 
2 of the patients. The results of this study, which mainly assessed the safety of using 
DBS in the AD population, led to the ongoing phase II clinical treatment trial that 
focuses on assessing its effects with comparisons to a non-treatment group. 
The Phase II longitudinal double-blind study (ADvance study) currently being 
conducted uses DBS-f in patients with mild AD. The hypothesis is that the stimulation 
treatment will alleviate memory deficits in the patients, as compared to those whose 
stimulation is turned off, throughout the one-year trial. The flicker change detection 
task that our lab previously developed (Chau et al, 2011) may prove to be a critical test 
of memory for this study.  
Atrophy of brain regions occurs variably across patients and over time, making 
it difficult for some of the already existing diagnostic tests to accurately report changes 
in memory. In addition, tests currently used with this population require verbal 
responses which may be confounded by age- or disease-related language deficits. Our 
change detection task is unique in that it relies on the eyes to be able to tell us about 
memory. Patients are shown flickering images where targets appear/disappear in 
alternation with the flicker, and are later repeated to test for target memory. Previously, 
our lab has shown that explicit recall for target objects in repeated trials yielded in 
faster detection of remembered targets than for forgotten ones. This eliminates the need 
for any verbal report from the patient and provides us with a more objective memory 
measure. DBS-f is a novel method of therapy for AD that targets hippocampal function, 
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hence evaluating its efficacy may be done best through the use of specific and selective 
hippocampal tasks. Consequently, we hypothesized that our nonverbal hippocampal-
dependent episodic target-in-scene detection task would perhaps prove to be more a 
sensitive assay in detecting memory changes over time in the ADvance study patients. 
To attempt to validate the use of this task with the AD population, we compared the 
measures of the task to some of the standardized tests currently being used in AD. 
 
MATERIALS AND METHODS 
Participants. 
Older adults with mild Alzheimer’s disease.   A total of 12 subjects (7 males and 5 
females; mean age) were selected from an already existing phase II clinical trial patient 
pool (the ADvance study). The ADvance study patients were selected based on the 
ADvance trial inclusion criteria as shown in table 1. The age range of patients were 
between 53-78 years, with an average age of 67.9 (SD=6.8). Written informed consent 
was obtained, and the study was conducted in accordance with protocols approved by 
University Health Network Research Ethics Board and the ethical guidelines set by the 
York Human Participants Review Subcommittee.  
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Table 1. Inclusion criteria for enrolling in the Advance study. Individuals chosen to 
participate in the Advance study must have met all 12 of the criteria listed in the table 
above. 
 
 
Task Design. 
 
Stimuli. The images used in this study were of natural scenes, selected and adjusted as 
described in Chapter 2. An example stimulus is presented in figure 1. 
 
Behavioral tasks. The change detection and target detection trial paradigms used were 
the same as described in Chapter 2. The design of the paradigms is shown in figure 1. 
 
Final change detection task. The final change detection task was comprised of 20 
‘remembered’ trials taken from previous sets, ranging from the Pre-op baseline to those 
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shown at the 9M testing time point. Remembered trials were defined as the repeated 
trials in which the target objects were found under the ‘remembered’ search time 
threshold (described further in the data analysis section). Occasionally, there were 
patients who had less than 20 remembered trials from the beginning of the study, thus 
to complete the final sets we added trials with the next fastest search times from 
previous sessions until the sets were complete. 
 
Behavioral testing procedure. 
Behavioral testing. Patients were tested at various time points throughout the one year 
study (figure 6). Two baseline measurements were taken; one baseline was taken one 
day before surgery (Pre-Op baseline), while the second baseline measurement was 
taken two weeks after surgery (Post-Op baseline), immediately before the treatment 
condition was applied. Each time point, or session, contained both flicker change and 
non-flicker target detection test sets. Change detection sets encompassed two blocks of 
20 images; within one block were 10 novel images, and then those same 10 images 
were repeated within the block in a non-specific order. Novel-repeat images were 
presented with lags of 1-6, meaning a novel image and its corresponding repeated 
image could be separated with 1-6 different images between them. A long-term target 
detection set was made up of the 10 images taken from the very first session (the Pre-
Op baseline), which were repeated sequentially to total 20 trials. Target detection sets 
were shown twice allowing patients to see each image 4 different times. The target 
detection set was shown to patients twice at the end of each session, after the two 
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session-specific flicker change detection sets were shown. Table 3 illustrates the data 
collected for each patient from the start of this study to the present day.  
 
Figure 5. Experimental testing paradigm. Patients were tested one day before 
undergoing surgery for electrode implantation (Baseline 1, Pre-Op) and again two 
weeks later (Baseline 2, Post-Op) prior to treatment assignment either receiving 
stimulation (stim) or not (sham). After treatment assignment, patients were tested at 
time points counted as one, three, six, nine, twelve, and fifteen months after the initial 
surgery. At the end of the twelve month visit, all patients had their devices turned on to 
receive chronic stimulation, whose effects could be monitored at the fifteen month time 
point. All sessions, except for the twelve month time point, included testing on two 
separate sets of the change detection test (20 novel trials; 20 repeated trials), followed 
by testing on the target detection test (10 images, repeated 3 times each). The twelve 
month testing time point included testing on one change detection set, followed by a 
final change detection set comprised of the most memorable images from prior change 
detection sets as defined in the task description. 
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Table 2. Patient data collected across time. This table provides an overview of the 
data (N=56) that has been collected from the 12 patients over a 15 month time period, 
where each ‘X’ signifies the session in which data was obtained. Occasionally, patients 
were unavailable for testing (empty blocks) due to medical complications or personal 
hardships. Baseline data is missing for 2 individuals (patients 2 and 3) due the start of 
this collaboration, as those patients had already begun the treatment prior to when we 
joined.   
 
 
ADvance study procedure. The ADvance study was designed to be a 12-month double-
blind, randomized, controlled study to assess the efficacy of a deep brain stimulation 
treatment to the fornix (DBS-f) in mild Alzheimer’s disease. After meeting inclusion 
criteria (table 1), patients underwent surgery to receive electrodes targeting the post-
commissural fornix. The study was randomized for treatment condition among the 
patients; one half of the subjects had the stimulation ‘turned on’ and set between 1-10V 
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(the highest voltage that did not elicit autonomic related symptoms to a maximum 
upper limit of 10V, tested per individual) two weeks post-surgery, while the other half 
had the stimulation turned on but set to an amplitude of 0 V (this treatment condition 
will be referred to as the ‘stimulation off’ group). Stimulation was set to a frequency of 
130Hz with a 90 microsecond pulse width. All study participants and experimenters of 
the study were blinded to the treatment assignment (stim or sham) throughout the entire 
study until after the last day of testing, which was done at the 12 month (12M) visit. 
After testing at the 12M visit, the devices from all the patients were turned on for 
chronic stimulation. My supervisor, Dr. Kari Hoffman, and I have, and will continue, to 
remain blind to all patient treatment conditions until all of the data analysis for the 
project is complete. A series of neuropsychological tests were planned for 
administration at various time points throughout the study, as outlined in table 2. 
 
 
Table 3. Advance study data collection. The table provides an overview of the data 
planned to be collected at each time point ranging from the pre-op (one day before 
surgery) and post-op (two weeks after surgery before the treatment condition is applied) 
baselines, to the 15 month time point. ADAS-cog = Alzheimer’s Disease Assessment 
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Scale – cognitive test; CVLT = California Verbal Learning Test; MRI = Magnetic 
Resonance Imaging; PET = Positron Emission Tomography.  
 
Data analysis. 
Data analysis. Search time and scene familiarity data analysis was done using MATLAB 
(version R2012a). A few trials displayed calibration inaccuracies, and were corrected in 
the same manner as described in chapter 2. Search times for each trial were corrected 
to exclude the time that participants spent looking outside of the screen dimensions. 
Trials were separated into novel and repeated categories, and the median search time 
for repeated trials was calculated for each session of each patient. ‘Remembered’ trials 
were determined by plotting a smoothed kernel density plot of repeated trial search 
times for all sessions per patient, and then taking the inflection point of the first curve 
from the repeated trials, as described in Chau et al. (2011). Scene familiarity was 
calculated by subtracting the False Positive Rate (FPR), defined as the novel trials 
reported as repeated, from the True Positive Rate (TPR), where participants correctly 
reported seeing a repeated image. Scene familiarity was given as an index, ranging 
from -1 to 1. The Pearson P correlation was calculated on the ADAS-cog-11 scores of 
all patients from all sessions, and their respective median repeated trial search times for 
those sessions, and was considered significant at an alpha of 0.05.  
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RESULTS 
 
Behavioral results. 
 
Figure 6. Median repeated search time across sessions. Median search time in seconds 
for target object detection in repeated trials plotted logarithmically for each patient over 
time. This transformation reveals the individual variability and progression over time, 
where shorter search times indicate better recall, and overall performance is seen to 
deteriorate across sessions. 
 
Median repeated search time for targets over time.  Although this was the first time this 
task was used with this clinical population, patients were able to do the task, and did 
not hit ceiling or floor with their median search time for targets in repeated trials. 
Though the data displays some degree of individual variability, the range for an 
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individual’s performance does not appear to fluctuate much over time. That is, high 
performers on this task seem to remain high performers over time and vice versa, with 
the exception of a few patients. 
 
Figure 7. Scene recognition from all patients across time. Familiarity of the scenes for 
all patients, defined as the difference between the False Positive Rate (novel trials 
reported as repeated) and the True Positive Rate (repeated images correctly reported as 
repeated), displayed as an index.  
 
Scene familiarity. Predictably, image recognition appeared to be easier for patients than 
the recollection of scene-specific targets, where majority of the scene familiarity rates 
were high. In fact, two patients even hit ceiling on this measure. However, this allows 
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us an opportunity to detect the expected declines in performance over time with disease 
progression. 
 
Figure 8. Median search time comparison with standardized measures (ADAS-cog). 
Median search time for target objects in repeated trials was compared to the ADAS-
cog, where lower scores on the ADAS-cog mean a better performance, and higher 
scores mean a worse performance. 
Median search time comparison with standardized measures (ADAS-cog). To aid in the 
validation of the change detection task with the Alzheimer’s population, median search 
time for target objects in repeated trials was compared to a standardized cognitive test 
commonly used with this clinical population, the ADAS-cog. Overall, there was a 
general trend for lower ADAS-cog scores corresponding to faster median search times. 
However, patients’ performances on the on the change detection task were quite 
variable beyond 25 seconds. As previously mentioned, the ADAS-cog is comprised of 
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multiple different subcomponents that test the function of various brain regions. These 
results suggest that this modified change detection task may be a sensitive measure of 
memory/decline in this particular clinical population. 
 
DISCUSSION 
We have previously shown that the change detection task requires hippocampal 
integrity, making any observed task performance changes partially dependent on 
changes in hippocampal function. Contrary to this, the ADAS-cog is a combination of 
mini-tasks that measure the function of various brain areas, thus it may not be the most 
optimal assay for measuring changes in hippocampal function specifically. The 
variability that we observed in median search time that was above 25 seconds when 
correlated with the ADAS-cog, where on the ADAS-cog scores did not differ by much, 
suggests that the change detection task may be detecting performance changes the 
ADAS-cog may not be.  Our rationale for this correlation was to attempt to validate the 
task with AD, which has never before been used with AD before, however doing so 
creates a dilemma. On the one hand, we have a task that measures hippocampal-
dependent memory, and so we think that in patients undergoing a stimulation treatment 
targeting hippocampal function, our task may be sensitive to detecting those changes. 
Attempting to validate this should be achievable by comparing it to a standardized 
measure already being used with the population, like the ADAS-cog. But on the other 
hand, we feel our task may be more sensitive to detecting changes in hippocampal 
function than the more general ADAS-cog, so we would not expect an extremely tight 
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correlation. Unblinding will help to shed more light on the observed results, and based 
on the sensitivity of this task, comparisons with other stages of AD and with other 
dementias may prove useful. 
Additional validation of this task could come from correlating time-dependent 
changes in task performance and hippocampal volume. As mentioned earlier, the 
hippocampus is one of the primary targets of AD, leading to atrophy of the structure. If 
change detection task performance were more correlated with hippocampal volume 
than performance on the ADAS-cog, it would be a convincing piece of evidence for 
illuminating the sensitivity of our task to changes in hippocampal function compared to 
the ADAS-cog.  
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Chapter 4: General conclusion and discussion 
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CONCLUSION 
 
Earlier diagnosis of AD may prove critical for better treatment results. 
Episodic/relational memory is one of the primary cognitive domains affected in 
individuals with AD, and yet the current tests used with the population assess more 
global declines. In addition, the memory subcomponents of current tests rely on verbal 
report for assessment, and may be confounded in those with language deficits whose 
memory is unaffected. In my Masters work, I set out to assess whether our non-verbal 
hippocampal-dependent flicker change detection task was sufficiently sensitive to 
identify memory decline attributed to normal aging, and more extensively affected in 
AD dementia. Whereas the task revealed that non-demented older adults (both healthy 
and at-risk) took longer to find target objects in repeated trials compared to a younger 
group, the search time impairment was greatest in those with AD dementia. The task 
also revealed that older individuals tend to make more fixations in repeated trials, with 
AD individuals fixating the most. Additionally, older adults have a more widespread 
fixation pattern than observed in younger adults, but were distinguished from those 
with AD whose fixations were even more dispersed. Whereas fixation and search time 
data could classify individuals with AD from an age-matched cohort, and those older 
adults from a younger group, these measures were unable to categorize the older adults 
into healthy and at-risk groups. Interestingly, we found that a memory-related pupillary 
response to image onset was only seen in healthy groups, not in the AD population or in 
at-risk older adults, suggesting that autonomic responses including the pupillary 
response may be a valuable diagnostic tool.  
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While the cause of AD is still being investigated, and no cure is in sight, 
researchers are aiming to develop effective treatment options for those diagnosed with 
the disease. The treatments now available for individuals with AD appear to be stage-
specific and elicit only temporary results.  It is known that persons with AD exhibit 
irregular epilepsy-like brain activity with increased risk for developing seizures 
(Amatniek et al., 2006; Yan et al., 2012; Palop & Mucke, 2011; Palop et al., 2007). In 
light of these findings, therapies that aim to modulate the activity of brain networks, 
then, may prove to be more effective in treating or reversing symptomology. After 
determining that the flicker change detection task was effective in detecting differences 
in memory performance between different groups, I sought to use the task in measuring 
memory performance in mild AD patients undergoing a novel AD therapy using 
stimulation.  In an attempt to validate the task for the clinical population, I compared 
target detection search time performance in repeated trials to ADAS-cog scores, and 
found a significant correlation between both measures. Although qualitatively the data 
showed a close association between lower ADAS-cog scores and faster search times, 
we observed an interesting dispersion of search time data beyond 25 seconds on the 
flicker change detection task. The longer search times that appeared scattered may be 
an indication of the task’s sensitivity overcoming that of the ADAS-cog. The non-
verbal measures of memory in this task did not show floor or ceiling effects, and 
trended with search times, where faster search times usually corresponded to higher 
scene familiarity rates. These measures were much easier, making it valuable for 
detecting declines expected over time with disease progression. Only after study 
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completion and treatment condition unblinding will I be able to comment on the 
efficacy of this new potential therapy on AD.  
 
LIMITATIONS 
 
Eye tracking. Many researchers are keen to use eye tracking to detail eye movements 
and provide gaze information, with the unique aspect that it may detect changes that 
may sometimes reflect subconscious efforts. While this collecting method has its 
advantages, it also has its drawbacks, particularly when used with older populations. It 
is fact that with normal aging, the eye changes. Older individuals have smaller pupils 
and experience trouble with focusing objects, leading to slight impairments in vision 
(Koretz et al., 1997). Many older adults rely on glasses for vision correction, and with 
thicker lens, the eye tracker we used was sometimes fooled into recognizing a glare 
spot. In turn, this led to difficulties in collecting eye tracking data, but was usually 
corrected with adjustments to camera settings and diode position.   
Older adults also become susceptible to developing age-related eye diseases, such as 
developing cataracts (Hodge et al., 1995). A cataract occurs when proteins in the eye 
lens begin to break down and create a clouded area as a result of the protein buildup. 
One of the fundamental factors for determining a good eye signal through the use of 
eye trackers is by identification of the pupil (Nixon, 2003). The eye tracker system we 
used measures the positions of 2 corneal reflectance spots relative to the pupil that are 
matched to specific locations on a screen.  A great amount of contrast between the pupil 
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and the iris needs to exist to be able to identify the pupil accurately. In AD patients who 
reported to have previous surgical correction for cataracts, I experienced difficulty with 
getting the tracker to outline the pupil, possibly due to the cloudy buildup making the 
pupil appear lighter and harder to distinguish from the rest of the eye. In patients with 
eye issues or vision problems, using touch screens or button press systems to identify 
detected target objects in repeated trials may prove to be a good alternative.  
Current neuropsychological tests used in AD. Current tests used measuring cognition 
claim to be sensitive and specific in identifying AD dementia and its prodromal stages. 
Studies on the Montreal Cognitive Assessment (MoCA) have shown that it is sensitive 
to detecting individuals with MCI using a threshold of 26 (out of a total of 30). 
However, in using this test with the older adults in the chapter 2 experiments, the 
limitations of this test became obvious. The MoCA consists of 8 different domains 
including a naming section (where participants are expected to name the animals they 
see pictured), a language section (where participants repeat an entire sentence after 
hearing it), and an abstraction section (where participants are asked to provide the 
commonality between two listed items). While the purpose of the naming section is to 
reveal any issues regarding object-naming, one version of the test that pictured a 
rhinoceros, was consistently mistaken for a hippopotamus. The rapidness in naming the 
animals mirrored the patient’s confidence in their ability to accurately label what they 
thought they saw. The participants that mistook the animals always correctly identified 
the other images just as quickly and confidently, lending support to probable failure of 
this section in classifying object-naming dysfunction in participants. Though losing one 
point may not seem like much, with only a small point range for individuals to remain 
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in the ‘healthy’ category (scoring 26-30), a one point deduction reflects a 25% decrease 
towards the ‘impaired’ range. Put in this way, the faulty image may have a significant 
difference on total scores, incorrectly labelling individuals as impaired when, in the 
absence of the image, they would have scored a 26.  
In addition to this error, we encountered a few problems with the abstraction 
section of the test. For the abstraction, participants were given pairs of items and asked 
to list something that the items had in common with each other (i.e. watch and ruler, 
were measurement tools). The MoCA scoring instructions detail the points assigned to 
only a few, very specific answers, which yielded in scoring errors. For example, the 
accepted answers given for the word pair ‘diamond-ruby’ were ‘gemstones’, ‘jewels’ 
and ‘precious stones’, while other answers were not accepted. One participant whose 
second language was English, provided ‘stone’ as an answer. Later analysis showed 
that the direct translation of ‘gemstone’ in the individual’s native tongue was, in fact, 
‘stone’. The language barrier for this particular word-pair resulted in an inaccurate 
immediate score, which we later accepted upon this realization. The participant clearly 
could connect the two items, and verbalize their commonality, yet the selectivity of 
acceptable answers made the participant appear as if they could not according to their 
score. In fact, it was not uncommon for language to affect a person’s total score, where 
when repeating the sentences in the language section, ESL participants often dropped 
‘a’ or ‘the’ reflecting the lack of these words in their native tongue. In conversing with 
these individuals before, after, and during breaks, it was quite obvious that these 
participants often forgot to include ‘a’ or ‘the’ in their speech. Having formed bad 
habits of not including these sorts of words in everyday speech, these individuals were 
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prime targets for failing the language parts of the test, however, not as a result of an 
actual cognitive impairment. These issues give rise to questions regarding the accuracy 
of detecting the milder abnormalities in cognitive function using tests such as the 
MoCA, due to some of the inconsistencies I listed. Furthermore, the MoCA, which is 
comprised of many different cognitive domains, may be a good indicator of global 
cognitive decline. Although, in diseases where memory seems to be the one of the first 
cognitive abilities impaired, such as in AD, the MoCA may not be the most optimal 
assay for differentiating those in the earliest stages of the disease. In fact, subtests more 
specific for memory are currently being designed (Julayanont et al., 2012). 
 
FUTURE DIRECTIONS 
One avenue to continue on for future analysis may include testing individuals with 
MCI.  We showed on our task that several test measures reflected a performance 
difference between those at-risk for developing the precursor of AD and those with AD, 
thus an appropriate speculation may be that those with MCI would show an 
intermediate impairment on the task compared to the other two groups. Additionally, 
several different types of MCI have been identified, only one of which shows clear 
impairments on memory (amnestic MCI). In knowing that the change detection task 
measures hippocampal-dependent memory, while those with amnestic MCI exhibit 
hippocampal atrophy and memory impairments, one would hypothesize that the task 
may potentially be able to separate the different MCI subtypes. Thus, testing 
individuals with different kind of MCI may help to validate the use of this task in 
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assessing memory. Although time-consuming, longitudinal testing of this paradigm 
with MCI individuals may prove the task to be a good predictor of susceptibility to the 
development of dementia, helping to identify those in need of early intervention. To 
further our findings regarding pupil responses, perhaps pupillary dynamics differ in the 
different stages of Alzheimer’s, and if so may be used to classify them. Finally, we 
observed other differences among the groups in their pupil responses to the flicker 
throughout the trial. Qualitatively, this could be seen in the pupils of healthy younger 
and older adults that reflected the alternating flicker, despite no mean luminance 
change. These pupil changes in response to the flicker appeared to be diminished in the 
at-risk and AD groups, in addition to the memory-related changes in pupil velocity. 
Future work may involve analyzing this aspect of pupil dynamics in different 
populations, including those with MCI.     
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